उत्पाद विवरण
Anaglob 1 mg Tablet is a potent aromatase inhibitor specifically designed for the management of hormone receptor-positive breast cancer, particularly in its early stages. By effectively reducing estrogen levels in the body, Anaglob hampers the growth and proliferation of cancer cells that rely on this hormone, making it an essential component of treatment strategies for patients with breast cancer. This medication is also recommended as a first-line therapy for advanced or metastatic breast cancer when the hormone receptor status is either positive or undetermined. Its important for patients to be aware of potential side effects, which may include hot flashes, joint pain, or fatigue, and to discuss these with their healthcare provider. Regular monitoring during treatment is crucial to ensure optimal efficacy and safety. As with any cancer treatment, adherence to prescribed dosages and schedules can significantly impact overall outcomes. If you or a loved one is facing a diagnosis of hormone receptor-positive breast cancer, consult your oncologist about how Anaglob 1 mg Tablet can fit into your personalized treatment plan.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese